Factors Affecting Therapeutic Efficacy of Vaginal Laser Therapy for Female Stress Urinary Incontinence, and the Effect of Vaginal Laser Therapy on Overactive Bladder Syndrome and Sexual Function
Sponsor:
Far Eastern Memorial Hospital
Collaborators:
Information provided by (Responsible Party):
Sheng-Mou Hsiao,Far Eastern Memorial Hospital
Tracking Information | |||
---|---|---|---|
First Submitted Date ICMJE | October 1, 2018 | ||
First Posted Date ICMJE | October 3, 2018 | ||
Last Update Posted Date | October 4, 2018 | ||
Actual Study Start Date ICMJE | September 5, 2018 | ||
Estimated Primary Completion Date | December 31, 2020 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures ICMJE |
Global response assessment[ Time Frame: 2 years ] |
||
Original Primary Outcome Measures ICMJE | Same as current | ||
Current Secondary Outcome Measures ICMJE |
|
||
Descriptive Information | |||
Brief Title ICMJE | Factors Affecting Therapeutic Efficacy of Vaginal Laser Therapy for Female Stress Urinary Incontinence, and the Effect of Vaginal Laser Therapy on Overactive Bladder Syndrome and Sexual Function |
||
Official Title ICMJE | Far Eastern Memorial Hospital |
||
Brief Summary | The main aim of this study is to elucidate factors affecting treatment efficacy of vaginal laser therapy. |
||
Detailed Description | Laser thermotherapy can increase the stiffness of vaginal wall. It has been reported that vaginal laser therapy can be used to treat stress urinary incontinence. However, factor affecting treatment efficacy of vaginal laser therapy remains unknown. Thus the main aim of this study is to elucidate factors affecting treatment efficacy of vaginal laser therapy. Besides, the durability of vaginal laser therapy will be assessed. The above knowledge should be helpful for clinical decision making. | ||
Study Type ICMJE | Observational | ||
Study Phase | |||
Study Design ICMJE | Allocation: Intervention Model: Intervention Model Description: Masking: Observational Masking Description: Primary Purpose: |
||
Condition ICMJE | |||
Intervention ICMJE |
|
||
Study Arms |
|
||
Recruitment Information | |||
Recruitment Status ICMJE | Recruiting | ||
Estimated Enrollment ICMJE |
200 | ||
Original Estimated Enrollment ICMJE | Same as current | ||
Estimated Study Completion Date | December 31, 2020 | ||
Estimated Primary Completion Date | December 31, 2020 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria ICMJE | Inclusion Criteria: - >20 years old female - had stress urinary incontinence symptoms - Sexual behavior - No urinary tract infection - At their own expense for vaginal laser therapy Exclusion Criteria: - Abnormal vaginal bleeding - Vaginal fistula | ||
Sex/Gender |
|
||
Ages | 20 Years and older (Adult, Older Adult) | ||
Accepts Healthy Volunteers | No | ||
Listed Location Countries ICMJE | Taiwan | ||
Removed Location Countries | |||
Administrative Information | Has Data Monitoring Committee | ||
U.S. FDA-regulated Product |
Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No |
||
IPD Sharing Statement |
|
||
Responsible Party | Sheng-Mou Hsiao,Far Eastern Memorial Hospital | ||
Study Sponsor ICMJE | Far Eastern Memorial Hospital | ||
Collaborators ICMJE | |||
Investigators ICMJE |
|
||
PRS Account | Far Eastern Memorial Hospital | ||
Verification Date | September 2018 | ||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
请使用微信扫码报名